Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome. - Derosa,G.; Gaddi,AV.; Piccinni,MN. (Pharmacotherapy, 2005)